Request for Applications: Postdoctoral Fellowship for Research Related to Tay-Sachs & Allied Diseases
Request for Applications: Postdoctoral Fellowship for Research Related to Tay-Sachs & Allied Diseases The CODRT Postdoctoral Fellowship provides a one-year grant of $35,000 to support the salary of a Fellow while working on a mentored project related to a CODRT-funded disease. Eligibility At the time of application, the applicant must possess a Ph.D., M.D., or V.M.D. and should not have completed more than 5 years of postdoctoral research. At the time of award, the applicant must not be simultaneously serving an internship or residency. Applicants must work for a non-profit institution or foundation, and ma...
Source: ScanGrants feed - September 3, 2014 Category: Research Authors: Center for Orphan Disease Research and Therapy University of Pennsylvania Source Type: funding
Request for Applications: Center for Orphan Disease Research and Therapy Postdoctoral Fellowship for Research Related to Hemophilia or Von Willebrand Disease
The CODRT Postdoctoral Fellowship provides a one‐year grant of $35,000 to support the salary of a Fellow while working on a mentored project related to a CODRT-funded disease. Eligibility At the time of application, the applicant must possess a Ph.D., M.D., or V.M.D. and should not have completed more than 5 years of postdoctoral research. At the time of award, the applicant must not be simultaneously serving an internship or residency. Applicants must work for a non-profit institution or foundation, and may not have a faculty appointment. There are no citizenship requirements for this program. Overview ...
Source: ScanGrants feed - September 3, 2014 Category: Research Authors: Center for Orphan Disease Research and Therapy University of Pennsylvania Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
Funding Opportunity Number: PAR-14-288 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) stat...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
Funding Opportunity Number: PAR-14-287 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2017Award Ceiling: $500,000Expected Number of Awards: Creation Date: Jul 18, 2014Funding Opportunity Description: This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorder...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
Funding Opportunity Number: PAR-14-286 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) stat...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
Funding Opportunity Number: PAR-14-289 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.853Eligible Applicants Small businessesAgency Name: HHS-NIH11Closing Date: May 07, 2017Award Ceiling: Expected Number of Awards: Creation Date: Jul 18, 2014Funding Opportunity Description: This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that ...
Source: Grants.gov - July 18, 2014 Category: Research Tags: Health Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (UH2/UH3)
Funding Opportunity PAR-14-288 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission. An identified candidate, which has sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to the CREATE Bio Developmen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding
NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)
Funding Opportunity PAR-14-289 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the development of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission.An identified candidate, which has sufficient bioactivity, stability, manufacturability, bioavailability, in vivo efficacy and/or target engagement, and other favorable properties that are consistent with the desired clinical application, is required for entry to the CREATE Bio Development ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U44)
Funding Opportunity PAR-14-287 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission.It supports the optimization of therapeutic lead(s) showing convincing proof-of-concept.At the end of the funding period, projects that successfully advance through support from this program will have identified an optimized candidate, which has sufficient bioactivity, stability, manufacturab...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding
NINDS CREATE Bio Discovery Track: Optimization in Preparation for Development of Biotechnology Products and Biologics (U01)
Funding Opportunity PAR-14-286 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is dedicated to the discovery of therapeutic Biotechnology Products and Biologics (e.g., peptides, proteins, oligonucleotides, gene therapies, and cell therapies) for disorders that fall under the NINDS mission. It supports the optimization of therapeutic lead(s) showing convincing proof-of-concept. At the end of the funding period, projects that successfully advance through support from this program will have identified a optimized candidate, which has sufficient bioactivity, stability, manufact...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 18, 2014 Category: Research Source Type: funding
Michael J. Fox Foundation for Parkinson’s Research Therapeutic Pipeline Program
Michael J. Fox Foundation for Parkinson’s Research Therapeutic Pipeline Program Spring 2015 Review Cycle Informational Conference Call*: September 19, 2014 at 12pm US ET Pre-Proposals Due: October 29, 2014 – 6pm US ET Full Proposal Invitations: November 19, 2014 Full Proposals Due (by invite only): January 14, 2015– 6pm US ET Anticipated Award Announcement: March 2015 Anticipated Funding: April 2015 *MJFF will hold a 45-minute conference call on the dates and times listed above to clarify and explain the goals of this funding initiative and answer applicant questions. ...
Source: ScanGrants feed - June 25, 2014 Category: Research Authors: Michael J. Fox Foundation for Parkinson’s Research Source Type: funding
Call for Applications: Alex's Lemonade Stand Foundation Bio-Therapeutics Impact Award
Call for Applications: Alex's Lemonade Stand Foundation Bio-Therapeutics Impact Award Application due date: June 12, 2014 (11:59 PM ET) All requests must be submitted using ALSF’s online application. Alex’s Lemonade Stand Foundation evolved from a young cancer patient’s front yard lemonade stand to a national foundation for childhood cancer. The Bio-Therapeutics Impact Award accelerates the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules. ...
Source: ScanGrants feed - March 17, 2014 Category: Research Authors: Alex's Lemonade Stand Foundation Source Type: funding
Beyond HAART: Innovative Approaches to Cure HIV-1 (U19)
Funding Opportunity Number: RFA-AI-14-004 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.24293.83993.85593.856Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits ha...
Source: Grants.gov - January 24, 2014 Category: Research Tags: Health Source Type: funding
Beyond HAART: Innovative Approaches to Cure HIV-1 (U19)
Funding Opportunity RFA-AI-14-004 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from institutions/organizations to participate in the "Beyond HAART: Innovative Approaches to Cure HIV-1" initiative. The purpose of this FOA is to encourage investigators to work together on innovative approaches to eliminate HIV-1 and leverage the expertise and resources of the participating Institutes. Research topics of interest are as follows: cell therapies, including those based on hematopoietic stem cells; novel gene therapy approaches; and the development and del...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 24, 2014 Category: Research Source Type: funding
Call for Applications: Cooley’s Anemia Foundation 2014-2015 Research Fellowships
Call for Applications: Cooley’s Anemia Foundation 2014-2015 Research Fellowships The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 Research Fellowships. Postdoctoral and junior faculty members investigating clinical or basic research related to thalassemia are eligible. Applications studying iron overload, iron chelation, methods of non-invasive iron measurement, quality of life, hepatitis C, osteoporosis, fertility, bone marrow transplantation and gene therapy are encouraged. Postdoctoral fellows should hold MD, PhD or equivalent degrees and requ...
Source: ScanGrants feed - December 3, 2013 Category: Research Authors: Cooley’s Anemia Foundation Source Type: funding
